Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276

Por Schmidt, J, Braggio, E, Kortuem, KM, Egan, JB, Zhu, YX, Xin, CS, Tiedemann, RE, Palmer, SE, Garbitt, VM, McCauley, D, Kauffman, M, Shacham, S, Chesi, M, Bergsagel, PL, Stewart, AK
Publicado em 2013